Най-четени статии по онкология
Top 10 Most Read Articles
by OncologySTAT Users
1. PARP Inhibitors Target Triple-Negative, BRCA-Deficient Breast Cancers
2. 10 Practice Changes I May Make Based on Presentations at the 2009 ASCO Meeting
3. Green Tea Polyphenols Block the Anticancer Effects of Bortezomib and Other Boronic Acid–Based Proteasome Inhibitors
4.Maintenance Pemetrexed Extends Survival in Lung Cancer
5.2009 Annual Meeting of the American Society of Clinical Oncology
6.Novel Cancer Therapies Aim to Destroy the Disease at Its Root: The Cancer Stem Cell
7.American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction
8.Second Vaccine Shows Improved Survival in Prostate Cancer
9.Bevacizumab Improves Progression-Free Survival for Glioblastoma Multiforme
10. NCCN Non−Small Cell Lung Cancer Guideline Updates Reflect 'Important Advances'
by OncologySTAT Users
1. PARP Inhibitors Target Triple-Negative, BRCA-Deficient Breast Cancers
2. 10 Practice Changes I May Make Based on Presentations at the 2009 ASCO Meeting
3. Green Tea Polyphenols Block the Anticancer Effects of Bortezomib and Other Boronic Acid–Based Proteasome Inhibitors
4.Maintenance Pemetrexed Extends Survival in Lung Cancer
5.2009 Annual Meeting of the American Society of Clinical Oncology
6.Novel Cancer Therapies Aim to Destroy the Disease at Its Root: The Cancer Stem Cell
7.American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction
8.Second Vaccine Shows Improved Survival in Prostate Cancer
9.Bevacizumab Improves Progression-Free Survival for Glioblastoma Multiforme
10. NCCN Non−Small Cell Lung Cancer Guideline Updates Reflect 'Important Advances'
Коментари